Kwivik Therapeutics Inc Funding & Investors

Kwivik Therapeutics Inc. is a pre-IPO medtech leader that has developed a novel way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this ''oxygen from powder'' technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of novel products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding a remarkable $750 Billion.